Clinical Trial Update: Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating combined modality therapy with growth factor support in unresectable locally advanced non-sma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Mt. Sinai Medical Center, Miami | Conditions: Unresectable Locally Advanced NSCLC | Phase 2 | Status: COMPLETED